Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report)’s stock price was up 24.6% during mid-day trading on Wednesday . The stock traded as high as $1.14 and last traded at $1.06. 2,994,528 shares were traded during trading, an increase of 138,215% from the average daily volume of 2,165 shares. The stock had previously closed at $0.8506.
Graybug Vision Stock Up 24.6%
The business has a 50 day simple moving average of $0.86 and a 200 day simple moving average of $1.76. The company has a market capitalization of $1.67 million, a PE ratio of -0.61 and a beta of 1.20.
Graybug Vision Company Profile
Graybug Vision, Inc is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for retinal diseases. The company’s proprietary Depot Technology Platform is designed to deliver sustained-release formulations of biologically active agents directly to the back of the eye, with the goal of reducing treatment burden and improving patient outcomes. Graybug’s lead product candidate, GB-102, is a long-acting formulation of sunitinib malate being investigated for the treatment of wet age-related macular degeneration (wet AMD).
Read More
- Five stocks we like better than Graybug Vision
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
